METROPOLITAN LIFE INSURANCE CO/NY - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 136 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2018. The put-call ratio across all filers is 1.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q3 2018$148,189
-99.9%
87,1700.0%0.00%
+50.0%
Q2 2018$151,676,000
+72.7%
87,170
+81.7%
0.00%
+100.0%
Q1 2018$87,806,000
+46855.1%
47,981
-42.7%
0.00%
-50.0%
Q4 2017$187,000
-55.8%
83,788
-42.6%
0.00%
-33.3%
Q3 2017$423,000
-38.8%
146,004
-6.0%
0.00%
-40.0%
Q2 2017$691,000
+10.0%
155,299
+15.2%
0.01%
+25.0%
Q1 2017$628,000
-19.2%
134,855
+5.6%
0.00%
-33.3%
Q4 2016$777,000
+5.6%
127,660
-4.4%
0.01%
+20.0%
Q3 2016$736,000
+42.4%
133,569
-1.9%
0.01%
+25.0%
Q2 2016$517,000
+136.1%
136,108
+71.8%
0.00%
+100.0%
Q1 2016$219,000
-51.2%
79,2390.0%0.00%
-33.3%
Q4 2015$449,000
+37.3%
79,239
+28.5%
0.00%
+50.0%
Q3 2015$327,000
-40.0%
61,661
-6.1%
0.00%
-50.0%
Q2 2015$545,000
+164.6%
65,643
-2.7%
0.00%
+300.0%
Q4 2014$206,000
+9.6%
67,4380.0%0.00%0.0%
Q3 2014$188,000
-31.4%
67,4380.0%0.00%
-50.0%
Q2 2014$274,000
-23.5%
67,4380.0%0.00%0.0%
Q1 2014$358,000
-5.8%
67,4380.0%0.00%
-33.3%
Q4 2013$380,000
+27.1%
67,438
+3.2%
0.00%
+50.0%
Q3 2013$299,000
+2.7%
65,362
-2.9%
0.00%0.0%
Q2 2013$291,00067,3260.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q3 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,273,509$9,493,0001.85%
Trellus Management Company, LLC 362,500$1,051,0001.44%
Paulson & Co. 24,062,368$69,781,0001.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 971,922$2,799,0001.09%
Asymmetry Capital Management, L.P. 271,102$786,0000.91%
Cheyne Capital Management (UK) LLP 651,500$1,880,0000.68%
Hikari Power Ltd 1,500,000$4,350,0000.56%
Orbimed Advisors 13,621,443$39,502,0000.38%
CARL DOMINO INC 83,000$241,0000.29%
KNOTT DAVID M 158,400$459,0000.20%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders